BelHealth Adds New Managing Director

BelHealth Adds New Managing Director

belhealth nf1Healthcare-focused private equity firm BelHealth Investment Partners has added Marc Aronstein to its team as a Managing Director.  Mr. Aronstein will be responsible for originating, structuring and executing new transactions.  Mr. Aronstein has twenty-three years of investing experience, including seventeen years of direct private equity experience.

Marc Aronstein nf1Mr. Aronstein was most recently a Managing Director and Co-Head of Private Equity Investing and Mergers and Acquisitions at The Marwood Group, where he led transactions and worked with lower middle market healthcare services companies. Prior to Marwood, he was a Managing Director at The Beekman Group, a private equity firm focused on investing in lower middle market companies.

Mr. Aronstein has an MBA from Harvard and a BS in Economics with a concentration in Finance from Wharton.

dennis drislane nf1“Marc is an experienced and successful healthcare investor and we look forward to his perspective as a key member of our investment team. As we grow, we are focused on adding talented and experienced individuals with a passion for healthcare investing,” said Dennis Drislane, BelHealth Managing Partner. “Marc has a long investment history, deep healthcare insight and experience and a track record of executing transactions in the lower middle market, and we are thrilled to welcome him to BelHealth.”

BelHealth Investment Partners is a lower middle market healthcare focused private equity firm.  The firm invests from $10 million to $40 million in companies in four healthcare segments: services, distribution, products, and information technology. BelHealth is based in New York (

© 2015 PEPD • Private Equity’s Leading News Magazine • 2-27-15

To search in site, type your keyword and hit enter